Search the Newsreel

KTOS Stock In Spotlight: Analyst Sees 37% Upside On Pentagon’s Defense Spending Momentum

First Citizens BancShares (FCNCA) Rises 1.02% as Regional Banking Momentum Builds - Imbalance Zone

Kratos Defense & Security Solutions (KTOS) Stock In Focus As US Tariffs Hit Imported Drones

Kratos Defense & Security Solutions (KTOS) is gaining attention after the U.S. government imposed new tariffs on imported drones and components, aiming to boost domestic production. As a U.S.-based drone and defense technology provider, Kratos is well-positioned to benefit from this policy shift, which …

EBITDA margin % of Liberty Defense Holdings Ltd. – DUS:4XS

The article displays the EBITDA margin percentage for Liberty Defense Holdings Ltd. (DUS:4XS) on the TradingView platform. It shows that the market is currently closed with no trades recorded. The content is primarily a data presentation, indicating financial information for the company on the …

SenseTime issues profit alert, expects to swing to first-half profit of over 500 million yuan

LNSR Looks 65.7% Overvalued on GF Value™

LENSAR Inc (LNSR) is set to discuss strategic updates at a virtual meeting on August 20, 2026. Despite a high Price-to-Sales ratio (2.0x) and being unprofitable, two prominent gurus have added to their positions. GuruFocus’ GF Value™ indicates LNSR is 65.7% overvalued, yet its …

ENSG Q2 2026 Earnings: EPS Beats Estimates by 2.16% as Stock Slips Modestly - Earnings Seasonality

Hensoldt-Aktie Prognose: Sollten Sie jetzt kaufen?

Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30, 2026

Citizens & Northern director Frank Pellegrino buys $5,244 in stock By Investing.com

Frank G. Pellegrino, a director at Citizens & Northern Corp (NASDAQ:CZNC), recently acquired 208 shares of the company's common stock for approximately $5,244. This transaction, executed on August 7, 2026, at $25.215 per share, increased Mr. Pellegrino's direct holdings to 51,108 shares. The purchase …

Genscript Biotech Posts Strong Core Growth but Reports Interim Loss on Legend Impact

Citizens, Inc. president & CEO Jon Stenberg buys $43,795 in stock

Citizens, Inc. President and CEO Jon Stenberg recently purchased 12,000 shares of the company's Class A Common Stock for $43,795, reflecting increased holdings when the stock is trading near its 52-week low. This transaction, made at $3.6496 per share on August 11, 2026, boosts …

The Ensign Group, Inc. (NASDAQ:ENSG) Given Average Recommendation of "Moderate Buy" by Brokerages

The Ensign Group, Inc. (NASDAQ:ENSG) has received an average "Moderate Buy" rating from brokerages, with an average 12-month price target of $216.25, suggesting potential upside from its current price of $181.65. The company recently reported strong quarterly results, beating earnings estimates with $1.92 per …

Citizens & Northern Corp Takes Position in Wells Fargo & Company $WFC

Trading the Move, Not the Narrative: (LNSR) Edition

This article provides an AI-generated analysis of Lensar Inc. (NASDAQ: LNSR), highlighting a strong near and mid-term sentiment but a weak long-term outlook. It indicates a breakout is underway with compelling upside potential due to no resistance levels remaining above the current price. The …

ABN AMRO Bank N.V. Takes $937,000 Position in The Ensign Group, Inc. $ENSG

ABN AMRO Bank N.V. has acquired a new position of 5,858 shares, valued at $937,000, in The Ensign Group, Inc. during the second quarter. This move comes as several other institutional investors have also adjusted their holdings in ENSG, with notable increases from Mitsubishi …

Bank of America Corp DE Sells 27,029 Shares of Kratos Defense & Security Solutions, Inc. $KTOS

Top Liberty Defense (DETX) Competitors 2026

Sensient technologies director Mario Ferruzzi sells $155,372 in stock By Investing.com

Sensient Technologies Corp director Mario Ferruzzi sold 1,200 shares of company stock for approximately $155,372. This transaction occurred on August 5, 2026, when the stock was trading near its 52-week high, and an InvestingPro analysis suggests the stock is currently overvalued. Following the sale, …

Genscript Biotech: AI-driven demand and platform scale drove record revenue and profit growth, with raised 2026 guidance

Genscript Biotech: Revenue up 27.3% and net profit up 203% year-over-year, driven by AI and platform scale

LNSR Q2 2026 Earnings: Strong EPS Beat vs. Estimates Despite Soft Share Reaction - Next Quarter Guidance

EXFY Q2 2026 Earnings: EPS Beats Estimates by 47%, Stock Climbs 3.6% - Energy Earnings Report

EnerSys (ENS) Is Up 6.1% After Record Q1 Earnings, Dividend Hike And Completed Buyback Program – Has The Bull Case Changed?

EnerSys reported strong fiscal first-quarter 2027 results, including record revenue and net income, a 10% dividend increase, and the completion of a share buyback program. These positive developments are viewed as a sign of management's confidence in the company's cash generation and capital return …

Sensient Technologies (SXT) Advances 2.68% to $133.47 as Specialty Ingredients Demand Drives Momentum - Long Short Pair

Valens Semiconductor Ltd. (NYSE:VLN) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

NNDM Q1 2026 Earnings: Loss of -0.34 per Share and 1.21 Stock Decline Highlight Ongoing Struggle - Post-Earnings Reaction

CZNC Q2 2026 Earnings: EPS Beats Estimates by 22.94% with $0.79 Reported - Next Quarter Guidance

Fancy Footwork: How to Play Birkenstock Stock After a Revenue Beat

Birkenstock Holding plc (BIRK) is proving that consumers may be cutting back, but they're not ready to give up their favorite pair of sandals just yet. Shares of the German footwear maker jumped 11.59% on Aug. 13 after its fiscal 2026 third-quarter results showed …

NeuroSense CEO Details Phase 3 ALS Trial Plans, Canada Filing and Nasdaq Compliance Efforts

NeuroSense Therapeutics has released a CEO letter detailing plans for its pivotal Phase 3 ALS trial of PrimeC, following FDA clearance. The company is actively pursuing various funding options for the trial and is preparing a New Drug Submission for PrimeC in Canada, targeted …

53,769 Shares in The Ensign Group, Inc. $ENSG Bought by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. recently acquired 53,769 shares of The Ensign Group, Inc. (NASDAQ:ENSG), valued at approximately $8.6 million, making them a new institutional investor in the company. Other institutional investors collectively own 96.12% of ENSG. The Ensign Group reported strong Q2 earnings, beating …

Assenagon Asset Management S.A. Has $1.18 Million Stock Position in First Citizens BancShares, Inc. $FCNCA

Citizens & Northern (NASDAQ:CZNC) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded Citizens & Northern (NASDAQ:CZNC) to a "strong-buy" rating. This follows other upgrades from Weiss Ratings and Zacks Research, although the overall analyst consensus remains "Hold" with a $23.50 target price. The company recently reported strong quarterly earnings of $0.79 per …

Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims on behalf of investors who suffered losses in The Ensign Group, Inc. (NASDAQ: ENSG). This investigation follows a short seller report alleging Ensign's business model relies on inadequate patient care and manipulated quality metrics, leading …

Dockside LLC Buys Shares of 13,600 The Ensign Group, Inc. $ENSG

Dockside LLC recently acquired 13,600 shares of The Ensign Group, Inc. (NASDAQ:ENSG) valued at approximately $2.18 million during the second quarter. Other institutional investors have also adjusted their positions in the company, which reported strong quarterly earnings, beating estimates with an EPS of $1.92 …

LENSAR (NASDAQ:LNSR) Upgraded at Wall Street Zen

Wall Street Zen upgraded LENSAR (NASDAQ:LNSR) from "sell" to "hold," aligning with the overall analyst consensus of "Hold" and an $11.00 price target. This upgrade follows LENSAR's positive quarterly earnings, which surpassed revenue and EPS expectations. The company also saw increased institutional investment and …